ANIKORA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ANIKORA Trademark

Serial Number: 97523022 • Registration: 7510795

ANIKORA is a trademark filed by CTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd. on July 27, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd. (4 trademarks)

Unit 301, 6399 Hutai Road
Baoshan, Shanghai 201908 , CN

Entity Type: 99

Trademark Details

Filing Date

July 27, 2022

Registration Date

September 24, 2024

Published for Opposition

July 9, 2024

Goods & Services

Pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hemoglobin; medicines for human purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; drugs for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 24, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 24, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 4, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 4, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 4, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 4, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2024 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 9, 2024 CHAN
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 8, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 8, 2024 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 8, 2024 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 6, 2024 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 7, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 7, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 7, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 7, 2024 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 6, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 6, 2023 GNSL
SUSPENSION LETTER WRITTEN
Nov 6, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2023 CRFA
ASSIGNED TO LIE
Oct 16, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 18, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 12, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
May 12, 2023 GNSL
SUSPENSION LETTER WRITTEN
May 12, 2023 CNSL
ASSIGNED TO EXAMINER
May 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2022 NWOS
NEW APPLICATION ENTERED
Jul 30, 2022 NWAP